Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?. (15th January 2021)
- Record Type:
- Journal Article
- Title:
- Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?. (15th January 2021)
- Main Title:
- Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?
- Authors:
- Francisqueti-Ferron, Fabiane Valentini
Garcia, Jéssica Leite
Ferron, Artur Junio Togneri
Nakandakare- Maia, Erika Tiemi
Gregolin, Cristina Schmitt
Silva, Janaina Paixão das Chagas
dos Santos, Klinsmann Carolo
Lo, Ângelo Thompson Colombo
Siqueira, Juliana Silva
de Mattei, Letícia
de Paula, Bruno Henrique
Sarzi, Felipe
Silva, Carol Cristina Vágula de Almeida
Moreto, Fernando
Costa, Mariane Róvero
Ferreira, Ana Lucia A.
Minatel, Igor Otávio
Corrêa, Camila Renata - Abstract:
- Abstract: The literature has reported a higher prevalence of negative clinical outcomes due to Coronavirus disease 19 (COVID-19) in obese individuals. This can be explained by the cytokine storm, result from the cytokine production from both obesity and viral infection. Gamma-oryzanol (γOz) is a compound with anti-inflammatory and antioxidant activities. However, little is known about the γOz action as a possible agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ). The aim of this study was to test the hypothesis that γOz attenuates the cytokine storm by stimulating PPAR-γ in the adipose tissue. Methods : Male Wistar rats were randomly divided into three experimental groups and fed ad libitum for 30 weeks with control diet (C, n = 6), high sugar-fat diet (HSF, n = 6) or high sugar-fat diet + γOz (HSF + γOz, n = 6). HSF groups also received water + sucrose (25%). The γOz dose was 0.5% in the chow. Evaluation in animals included caloric intake, body weight, adiposity index, plasma triglycerides, and HOMA-IR. In adipose tissue was evaluated: PPAR-γ gene and protein expression, inflammatory and oxidative stress parameters, and histological analysis. Results: Adipose tissue dysfunction was observed in HSF group, which presented remarkable PPAR-γ underexpression and increased levels of cytokines, other inflammatory markers and oxidative stress. The γOz treatment prevented adipose tissue dysfunction and promoted PPAR-γ overexpression. Conclusion: Natural compoundsAbstract: The literature has reported a higher prevalence of negative clinical outcomes due to Coronavirus disease 19 (COVID-19) in obese individuals. This can be explained by the cytokine storm, result from the cytokine production from both obesity and viral infection. Gamma-oryzanol (γOz) is a compound with anti-inflammatory and antioxidant activities. However, little is known about the γOz action as a possible agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ). The aim of this study was to test the hypothesis that γOz attenuates the cytokine storm by stimulating PPAR-γ in the adipose tissue. Methods : Male Wistar rats were randomly divided into three experimental groups and fed ad libitum for 30 weeks with control diet (C, n = 6), high sugar-fat diet (HSF, n = 6) or high sugar-fat diet + γOz (HSF + γOz, n = 6). HSF groups also received water + sucrose (25%). The γOz dose was 0.5% in the chow. Evaluation in animals included caloric intake, body weight, adiposity index, plasma triglycerides, and HOMA-IR. In adipose tissue was evaluated: PPAR-γ gene and protein expression, inflammatory and oxidative stress parameters, and histological analysis. Results: Adipose tissue dysfunction was observed in HSF group, which presented remarkable PPAR-γ underexpression and increased levels of cytokines, other inflammatory markers and oxidative stress. The γOz treatment prevented adipose tissue dysfunction and promoted PPAR-γ overexpression. Conclusion: Natural compounds as γOz can be considered a coadjutant therapy to prevent the cytokine storm in COVID-19 patients with obesity conditions. Highlights: Gamma oryzanol is a compound of rice bran with anti-inflammatory and antioxidant action in adipose tissue. Insulin resistance, dyslipidemia and cardiac dysfunction were attenuated by gamma oryzanol. PPAR-gamma increases its expression with gamma oryzanol in adipose tissue. Gamma oryzanol may be an alternative compound in the treatment of cytokine storm in obese individuals with COVID-19. … (more)
- Is Part Of:
- Molecular and cellular endocrinology. Volume 520(2021)
- Journal:
- Molecular and cellular endocrinology
- Issue:
- Volume 520(2021)
- Issue Display:
- Volume 520, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 520
- Issue:
- 2021
- Issue Sort Value:
- 2021-0520-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01-15
- Subjects:
- Obesity -- COVID-19 -- Gamma-oryzanol -- PPAR-γ
Endocrinology -- Periodicals
Molecular biology -- Periodicals
Cytology -- Periodicals
Endocrinology -- Periodicals
Hormones -- Periodicals
Endocrinologie -- Périodiques
Cytology
Endocrinology
Molecular biology
Periodicals
573.4 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03037207 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.mce.2020.111095 ↗
- Languages:
- English
- ISSNs:
- 0303-7207
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.760000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25605.xml